PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients

Anwar Padhani

August 2016

Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...

Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies

Bollineni, Vikram R
Koole, Michel
Pruim, Jan
Brouwer, Charlotte L
Wiegman, Erwin M
Groen, Harry JM
Vlasman, Renske
Halmos, Gyorgy B
Oosting, Sjoukje F
Langendijk, Johannes A
Widder, Joachim
Steenbakkers, Roel JHM

November 2014

To define the optimal time point for the integration of hypoxia (18)F-FAZA-PET/CT information into r...

R.(2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy

Susanne-martina Eschmann
Md Frank Paulsen
Md Matthias Reimold
Md Helmut Dittmann
Stefan Welz
Md Gerald Reischl
Phd Hans-juergen Machulla

April 2015

In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC), hypoxia is kno...

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients

Bollineni, Vikram R
Kerner, Gerald S M A
Pruim, Jan
Steenbakkers, Roel J H M
Wiegman, Erwin M
Koole, Michel
de Groot, Eleonore H
Willemsen, Antoon T M
Luurtsema, Gert
Widder, Joachim
Groen, Harry J M
Langendijk, Johannes A

August 2013

Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...

PET Imaging of Tumor Hypoxia Using F-18-Fluoroazomycin Arabinoside in Stage III-IV Non-Small Cell Lung Cancer Patients

Bollineni, Vikram R.
Kerner, Gerald S. M. A.
Pruim, Jan
Steenbakkers, Roel J. H. M.
Wiegman, Erwin M.
Koole, Michel J. B.
de Groot, Eleonore H.
Willemsen, Antoon T. M.
Luurtsema, Gert
Widder, Joachim
Groen, Harry J. M.
Langendijk, Johannes A.

August 2013

Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...

Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: A review

Halmos, Gyorgy B.
de Bruin, Leonie Bruine
Langendijk, Johannes A.
van der Laan, Bernard F. A. M.
Pruim, Jan
Steenbakkers, Roel J. H. M.

January 2014

Tumor hypoxia is known to be associated with poor clinical outcome; therefore, patients with hypoxic...

Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET:A review

Halmos, Gyorgy B.
de Bruin, Leonie Bruine
Langendijk, Johannes A.
van der Laan, Bernard F. A. M.
Pruim, Jan
Steenbakkers, Roel J. H. M.

January 2014

Tumor hypoxia is known to be associated with poor clinical outcome; therefore, patients with hypoxic...

An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)

Kerner, Gerald S. M. A.
Bollineni, Vikram R.
Hiltermann, Thijo J. N.
Sijtsema, Nanna M.
Fischer, Alexander
Bongaerts, Alphons H. H.
Pruim, Jan
Groen, Harry J. M.

April 2016

Background: Hypoxia is associated with resistance to chemotherapy and radiotherapy and is randomly d...

Initial Report on [18F]FAZA-PET/CT Clinical Study in Lung Cancer

Inubushi Masayuki
Koizumi Mitsuru
Saga Tsuneo

February 2019

Aim: The aim of the clinical study is to investigate whether PET imaging with a hypoxia tracer [18F]...

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer

Thureau, Sébastien
Piton, Nicolas
Gouel, Pierrick
Modzelewski, Romain
Dujon, Antoine
Baste, Jean-Marc
Melki, Jean
Rinieri, Philippe
Peillon, Christophe
Rastelli, Olivier
Lequesne, Justine
Hapdey, Sébastien
Sabourin, Jean-Christophe
Bohn, Pierre
Vera, Pierre

August 2021

International audienceHypoxic areas are typically resistant to treatment. However, the fluorine-18-f...

Longitudinal tumor hypoxia imaging with [18F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity

Zheng, Jinzi
Klinz, Stephan G
De Souza, Raquel
Fitzgerald, Jonathan
Jaffray, David A.

March 2018

Abstract Background Non-invasive measurement of tumor...

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.

Busk, M.
Horsman, M.R.
Jakobsen, S.
Keiding, S.
Kogel, A.J. van der
Bussink, J.
Overgaard, J.

January 2008

PURPOSE: Positron emission tomography (PET) allows noninvasive assessment of tumor hypoxia; however ...

A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy

Servagi Vernat, Stéphanie
Differding, Sarah
Hanin, François-Xavier
Labar, Daniel
Bol, Anne
Lee, John Aldo
Grégoire, Vincent

January 2014

PURPOSE: Hypoxia in head and neck squamous cell carcinoma (HNSCC) is associated with poor prognosis ...

Clinical value of FAZA-PET/CT in advanced lung cancer patients: comparison with FDG-PET/CT

Saga Tsuneo
Inubushi Masayuki
Koizumi Mitsuru
Yoshikawa Kyosan
Zhang Ming-Rong
Horiike Atsushi
Yanagitani Noriko
Ohyanagi Fumiyoshi
Nishio Makoto

February 2019

Objective: The presence of hypoxia in cancer tissue is known to increase not only their refractorine...

Pretreatment 18F-FAZA PET Predicts Success of Hypoxia-Directed Radiochemotherapy Using

Roswitha Beck
Janette Maria Carlsen
Marc Cornelis Huisman
Julia Aloisia Lebschi
Nicolaus Andratschke
Maria Picchio
Michael Souvatzoglou

March 2015

We evaluated the predictive value of PET using the hypoxia tracer 18F-fluoroazomycin arabinoside (18...

PET imaging of tumour hypoxia

Anwar Padhani

August 2016

Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...

Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies

Bollineni, Vikram R
Koole, Michel
Pruim, Jan
Brouwer, Charlotte L
Wiegman, Erwin M
Groen, Harry JM
Vlasman, Renske
Halmos, Gyorgy B
Oosting, Sjoukje F
Langendijk, Johannes A
Widder, Joachim
Steenbakkers, Roel JHM

November 2014

To define the optimal time point for the integration of hypoxia (18)F-FAZA-PET/CT information into r...

R.(2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy

Susanne-martina Eschmann
Md Frank Paulsen
Md Matthias Reimold
Md Helmut Dittmann
Stefan Welz
Md Gerald Reischl
Phd Hans-juergen Machulla

April 2015

In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC), hypoxia is kno...

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients

Bollineni, Vikram R
Kerner, Gerald S M A
Pruim, Jan
Steenbakkers, Roel J H M
Wiegman, Erwin M
Koole, Michel
de Groot, Eleonore H
Willemsen, Antoon T M
Luurtsema, Gert
Widder, Joachim
Groen, Harry J M
Langendijk, Johannes A

August 2013

Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...

PET Imaging of Tumor Hypoxia Using F-18-Fluoroazomycin Arabinoside in Stage III-IV Non-Small Cell Lung Cancer Patients

Bollineni, Vikram R.
Kerner, Gerald S. M. A.
Pruim, Jan
Steenbakkers, Roel J. H. M.
Wiegman, Erwin M.
Koole, Michel J. B.
de Groot, Eleonore H.
Willemsen, Antoon T. M.
Luurtsema, Gert
Widder, Joachim
Groen, Harry J. M.
Langendijk, Johannes A.

August 2013

Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...

Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: A review

Halmos, Gyorgy B.
de Bruin, Leonie Bruine
Langendijk, Johannes A.
van der Laan, Bernard F. A. M.
Pruim, Jan
Steenbakkers, Roel J. H. M.

January 2014

Tumor hypoxia is known to be associated with poor clinical outcome; therefore, patients with hypoxic...

Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET:A review

Halmos, Gyorgy B.
de Bruin, Leonie Bruine
Langendijk, Johannes A.
van der Laan, Bernard F. A. M.
Pruim, Jan
Steenbakkers, Roel J. H. M.

January 2014

Tumor hypoxia is known to be associated with poor clinical outcome; therefore, patients with hypoxic...

An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)

Kerner, Gerald S. M. A.
Bollineni, Vikram R.
Hiltermann, Thijo J. N.
Sijtsema, Nanna M.
Fischer, Alexander
Bongaerts, Alphons H. H.
Pruim, Jan
Groen, Harry J. M.

April 2016

Background: Hypoxia is associated with resistance to chemotherapy and radiotherapy and is randomly d...

Initial Report on [18F]FAZA-PET/CT Clinical Study in Lung Cancer

Inubushi Masayuki
Koizumi Mitsuru
Saga Tsuneo

February 2019

Aim: The aim of the clinical study is to investigate whether PET imaging with a hypoxia tracer [18F]...

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer

Thureau, Sébastien
Piton, Nicolas
Gouel, Pierrick
Modzelewski, Romain
Dujon, Antoine
Baste, Jean-Marc
Melki, Jean
Rinieri, Philippe
Peillon, Christophe
Rastelli, Olivier
Lequesne, Justine
Hapdey, Sébastien
Sabourin, Jean-Christophe
Bohn, Pierre
Vera, Pierre

August 2021

International audienceHypoxic areas are typically resistant to treatment. However, the fluorine-18-f...

Longitudinal tumor hypoxia imaging with [18F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity

Zheng, Jinzi
Klinz, Stephan G
De Souza, Raquel
Fitzgerald, Jonathan
Jaffray, David A.

March 2018

Abstract Background Non-invasive measurement of tumor...

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.

Busk, M.
Horsman, M.R.
Jakobsen, S.
Keiding, S.
Kogel, A.J. van der
Bussink, J.
Overgaard, J.

January 2008

PURPOSE: Positron emission tomography (PET) allows noninvasive assessment of tumor hypoxia; however ...

A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy

Servagi Vernat, Stéphanie
Differding, Sarah
Hanin, François-Xavier
Labar, Daniel
Bol, Anne
Lee, John Aldo
Grégoire, Vincent

January 2014

PURPOSE: Hypoxia in head and neck squamous cell carcinoma (HNSCC) is associated with poor prognosis ...

Clinical value of FAZA-PET/CT in advanced lung cancer patients: comparison with FDG-PET/CT

Saga Tsuneo
Inubushi Masayuki
Koizumi Mitsuru
Yoshikawa Kyosan
Zhang Ming-Rong
Horiike Atsushi
Yanagitani Noriko
Ohyanagi Fumiyoshi
Nishio Makoto

February 2019

Objective: The presence of hypoxia in cancer tissue is known to increase not only their refractorine...

Pretreatment 18F-FAZA PET Predicts Success of Hypoxia-Directed Radiochemotherapy Using

Roswitha Beck
Janette Maria Carlsen
Marc Cornelis Huisman
Julia Aloisia Lebschi
Nicolaus Andratschke
Maria Picchio
Michael Souvatzoglou

March 2015

We evaluated the predictive value of PET using the hypoxia tracer 18F-fluoroazomycin arabinoside (18...

PET imaging of tumour hypoxia

Anwar Padhani

August 2016

Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...

Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies

Bollineni, Vikram R
Koole, Michel
Pruim, Jan
Brouwer, Charlotte L
Wiegman, Erwin M
Groen, Harry JM
Vlasman, Renske
Halmos, Gyorgy B
Oosting, Sjoukje F
Langendijk, Johannes A
Widder, Joachim
Steenbakkers, Roel JHM

November 2014

To define the optimal time point for the integration of hypoxia (18)F-FAZA-PET/CT information into r...

R.(2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy

Susanne-martina Eschmann
Md Frank Paulsen
Md Matthias Reimold
Md Helmut Dittmann
Stefan Welz
Md Gerald Reischl
Phd Hans-juergen Machulla

April 2015

In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC), hypoxia is kno...

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients

Abstract

Extracted data

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients

Abstract

Extracted data

Related items

Related items